[ISIS-2, an international study of survival after a heart infarct: the power of large numbers?].
作者信息
Koster R W
出版信息
Ned Tijdschr Geneeskd. 1989 Feb 18;133(7):338-40.
PMID:2648174
Abstract
摘要
相似文献
1
[ISIS-2, an international study of survival after a heart infarct: the power of large numbers?].
Ned Tijdschr Geneeskd. 1989 Feb 18;133(7):338-40.
2
[Systemic thrombolysis using streptokinase. Experiences at the Civic Hospital of Lugano in the framework of the ISIS-2 study].
Schweiz Med Wochenschr. 1988 Nov 19;118(46):1702-5.
3
4
5
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):3A-13A. doi: 10.1016/0735-1097(88)92635-6.
6
7
[First results of a randomized study of intravenous thrombolytic therapy in acute myocardial infarct--evaluation of the early period].
Vnitr Lek. 1988 Dec;34(12):1145-54.
8
[ISIS-2--a study of patients with myocardial infarction. A combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke].
Lakartidningen. 1988 Aug 31;85(35):2759-64.
9
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
BMJ. 1998 May 2;316(7141):1337-43. doi: 10.1136/bmj.316.7141.1337.
10
Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2.
Lancet. 1987 Feb 28;1(8531):502.
Zotero 插件